Hudson Frederick M.
SEC CIK 1438462 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Dir | 60.4K | — | $1.16M | 13 | 2022-02-19 | 2026-03-12 |
Most active insiders at SUPN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Khattar Jack A. | Pres, CEO, Dir | — | $7.72M |
| 2 | Bhatt Padmanabh P. | CSO, SVP of IP | — | $5.42M |
| 3 | NEWHALL CHARLES W III | Dir | — | $1.27M |
| 4 | Mottola Frank | SVP, Chief Tech. Ops. Off | — | $1.10M |
| 5 | GEMAYEL GEORGES | Dir | — | $1.00M |
| 6 | Horich William Todd | SVP, Commercial Ops | — | $483.8K |
| 7 | Hudson Frederick M. | Dir | — | $271.7K |
| 8 | Sensenig Bethany | Dir | — | $228.3K |
| 9 | Rubin Jonathan | SVP, Chief Medical Off | — | — |
| 10 | Barlow Carrolee | Dir | — | — |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-16 | 2026-03-12 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Hudson Frederick M. | Dir | S - Sale | $50.61 | -5,369 | 60.4K | -8% | -$271.7K | |
| D | 2026-02-25 | 2026-02-24 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Hudson Frederick M. | Dir | A - Grant | $0.00 | +4,475 | 65.8K | +7% | $0 |
| D | 2026-01-12 | 2026-01-09 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Hudson Frederick M. | Dir | M - OptEx | $12.98 | +15.0K | 61.3K | +32% | +$194.7K |
| 2025-08-18 | 2025-08-14 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Hudson Frederick M. | Dir | S - Sale | $42.26 | -7,457 | 46.3K | -14% | -$315.1K | |
| D | 2025-02-24 | 2025-02-22 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Hudson Frederick M. | Dir | A - Grant | $0.00 | +5,369 | 53.8K | +11% | $0 |
| D | 2025-01-23 | 2025-01-22 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Hudson Frederick M. | Dir | M - OptEx | $9.13 | +20.0K | 48.4K | +70% | +$182.6K |
| 2024-11-12 | 2024-11-08 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Hudson Frederick M. | Dir | S - Sale | $36.28 | -8,722 | 28.4K | -23% | -$316.4K | |
| D | 2024-02-27 | 2024-02-23 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Hudson Frederick M. | Dir | A - Grant | $0.00 | +3,886 | 37.1K | +12% | $0 |
| DM | 2023-11-17 | 2023-11-15 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Hudson Frederick M. | Dir | S - Sale+OE | $28.50 | -9,093 | 33.2K | -21% | -$259.2K |
| D | 2023-11-17 | 2023-11-15 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Hudson Frederick M. | Dir | M - OptEx | $9.24 | +7,457 | 42.3K | +21% | +$68.9K |
| D | 2023-02-24 | 2023-02-22 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Hudson Frederick M. | Dir | A - Grant | $0.00 | +3,882 | 34.9K | +13% | $0 |
| D | 2023-01-12 | 2023-01-10 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Hudson Frederick M. | Dir | M - OptEx | $7.90 | +8,722 | 31.0K | +39% | +$68.9K |
| D | 2022-02-23 | 2022-02-19 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Hudson Frederick M. | Dir | A - Grant | $0.00 | +4,222 | 22.3K | +23% | $0 |
Purchase Sale Sale after option exercise All abbreviations